About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5894 record(s)
Req # A-2019-001988
Adverse Reaction Report (AER). Report number: E2B_02743108.Organization: Health Canada
April 2020
Req # A-2019-002019
Adverse Reaction Report (AER). Report number: 000728386.Organization: Health Canada
April 2020
Req # A-2019-002033
Adverse Reaction Report (AER). Report number: E2B_02691252.Organization: Health Canada
April 2020
Req # A-2019-002079
Adverse Reaction Report (AER) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_02647196.Organization: Health Canada
April 2020
Req # A-2019-002083
Adverse Reaction Report (AER). Report number: E2B_02699083.Organization: Health Canada
April 2020
Nothing to report this month
Organization: Canadian Grain Commission
Nothing to report this month
Organization: The Seaway International Bridge Corporation
Req # A-2019-001850
Adverse Reaction Report (AER). Report number: E2B_02781314.Organization: Health Canada
March 2020
Req # A-2015-000172
All documentation regarding the establishment of bioequivalence or therapeutic or clinical equivalence of subsequent-entry inhaled respiratory medication.Organization: Health Canada
March 2020
Req # A-2018-001153
All Briefing Notes regarding the suspension and potential revocation of Agrima Botanicals Corp (Ascent Industries Corp. subsidiary) from September 1, 2018 to December 31, 2018.Organization: Health Canada
March 2020